LBRX
Common StockLB PHARMACEUTICALS INC
Reported Shares
630.7K
Position Mix
No options reported
Reported Value
$24.2M
Portfolio Weight
16.17%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$149.7M
Data Refreshed
Nov 16, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
LBRX
Common StockLB PHARMACEUTICALS INC
Reported Shares
630.7K
Position Mix
No options reported
Reported Value
$24.2M
Portfolio Weight
16.17%
MPLT
Common StockMapLight Therapeutics, Inc.
Reported Shares
2.3M
Position Mix
No options reported
Reported Value
$23.4M
Portfolio Weight
15.66%
OBX
Common StockObsidian Therapeutics, Inc.
Reported Shares
918.8K
Position Mix
No options reported
Reported Value
$12.6M
Portfolio Weight
8.43%
HELP
Common StockHelus Pharma Inc.
Reported Shares
987.2K
Position Mix
No options reported
Reported Value
$12.1M
Portfolio Weight
8.11%
EVMN
Common StockEvommune, Inc.
Reported Shares
1.4M
Position Mix
No options reported
Reported Value
$11.9M
Portfolio Weight
7.95%
NUVB
Common StockNuvation Bio Inc.
Reported Shares
1.3M
Position Mix
No options reported
Reported Value
$7.4M
Portfolio Weight
4.97%
INCY
Common StockINCYTE CORP
Reported Shares
53.7K
Position Mix
No options reported
Reported Value
$6.5M
Portfolio Weight
4.36%
ONC
Depositary ReceiptBeOne Medicines Ltd.
Reported Shares
15.7K
Position Mix
No options reported
Reported Value
$5.8M
Portfolio Weight
3.84%
RYTM
Common StockRHYTHM PHARMACEUTICALS, INC.
Reported Shares
49.1K
Position Mix
No options reported
Reported Value
$4.7M
Portfolio Weight
3.12%
PCOR
Common StockPROCORE TECHNOLOGIES, INC.
Reported Shares
88.8K
Position Mix
No options reported
Reported Value
$4.6M
Portfolio Weight
3.07%
NAMS
Common StockNewAmsterdam Pharma Co N.V.
Reported Shares
165K
Position Mix
No options reported
Reported Value
$4.0M
Portfolio Weight
2.68%
RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
19.3K
Position Mix
No options reported
Reported Value
$4.0M
Portfolio Weight
2.64%
KYMR
Common StockKymera Therapeutics, Inc.
Reported Shares
30.9K
Position Mix
No options reported
Reported Value
$3.5M
Portfolio Weight
2.31%
ASND
Common StockAscendis Pharma A/S
Reported Shares
13.6K
Position Mix
No options reported
Reported Value
$3.1M
Portfolio Weight
2.07%
MDGL
Common StockMADRIGAL PHARMACEUTICALS, INC.
Reported Shares
5.7K
Position Mix
No options reported
Reported Value
$2.9M
Portfolio Weight
1.91%
OCS
Common StockOculis Holding AG
Reported Shares
300.6K
Position Mix
No options reported
Reported Value
$2.8M
Portfolio Weight
1.88%
ARGX
Depositary ReceiptARGENX SE
Reported Shares
2.8K
Position Mix
No options reported
Reported Value
$2.7M
Portfolio Weight
1.79%
TCGX
Common StockTCGX Acquisition Corp.
Reported Shares
200K
Position Mix
No options reported
Reported Value
$2.5M
Portfolio Weight
1.67%
CELC
Common StockCelcuity Inc.
Reported Shares
28.3K
Position Mix
No options reported
Reported Value
$2.3M
Portfolio Weight
1.50%
ACAD
Common StockACADIA PHARMACEUTICALS INC
Reported Shares
103K
Position Mix
No options reported
Reported Value
$2.1M
Portfolio Weight
1.39%